{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:32:54Z","timestamp":1788834774864,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.anai.2022.09.011","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T02:54:35Z","timestamp":1663296875000},"page":"84-92.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Beta-lactam hypersensitivity diagnosis in ambulatory and hospitalized settings require different approaches"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-4123","authenticated-orcid":false,"given":"Yuda","family":"Chongpison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirinoot","family":"Palapinyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pungjai","family":"Mongkolpathumrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supranee","family":"Buranapraditkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattarawat","family":"Thantiworasit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6063-2403","authenticated-orcid":false,"given":"Jettanong","family":"Klaewsongkram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.anai.2022.09.011_bib0001","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1016\/j.jaip.2020.04.059","article-title":"Penicillin allergy delabeling: a multidisciplinary opportunity","volume":"8","author":"Staicu","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2022.09.011_bib0002","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jaci.2015.10.026","article-title":"Consequences of avoiding beta-lactams in patients with beta-lactam allergies","volume":"137","author":"Jeffres","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2022.09.011_bib0003","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/cid\/ciw462","article-title":"Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study","volume":"63","author":"MacFadden","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.anai.2022.09.011_bib0004","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: a cohort study","volume":"133","author":"Macy","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.09.011_bib0005","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/cid\/ciaa194","article-title":"Penicillin allergy testing is cost-saving: an economic evaluation study","volume":"72","author":"Sousa-Pinto","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.anai.2022.09.011_bib0006","first-page":"136","article-title":"Penicillin allergy assessment and skin testing in the outpatient setting","volume":"7","author":"Kufel","year":"2019","journal-title":"Pharmacol (Basel)"},{"issue":"5","key":"10.1016\/j.anai.2022.09.011_bib0007","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","article-title":"Development and validation of a penicillin allergy clinical decision rule","volume":"180","author":"Trubiano","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.anai.2022.09.011_bib0008","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1398-9995.2009.02228.x","article-title":"Determining the negative predictive value of provocation tests with beta-lactams","volume":"65","author":"Demoly","year":"2010","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2022.09.011_bib0009","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jaip.2017.03.032","article-title":"\u201cTreating Through\u201d decision and follow-up in antibiotic therapy-associated exanthemas","volume":"5","author":"Trautmann","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.anai.2022.09.011_bib0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025247","article-title":"\u03b2-lactams and \u03b2-lactamase inhibitors: an overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"10.1016\/j.anai.2022.09.011_bib0011","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cid\/ciu126","article-title":"Severe cutaneous adverse reactions related to systemic antibiotics","volume":"58","author":"Lin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.anai.2022.09.011_bib0012","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brockow","year":"2002","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2022.09.011_bib0013","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs\u2014an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2022.09.011_bib0014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5414\/ALX02104E","volume":"4","author":"Wurpts","year":"2020","journal-title":"Allergol Select"},{"issue":"9S","key":"10.1016\/j.anai.2022.09.011_bib0015","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2022.09.011_bib0016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0536.2009.01659.x","article-title":"Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)","volume":"62","author":"Santiago","year":"2010","journal-title":"Contact Dermatitis"},{"issue":"5","key":"10.1016\/j.anai.2022.09.011_bib0017","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.anai.2010.12.020","article-title":"The diagnostic value of basophil activation test in patients with an immediate hypersensitivity reaction to radiocontrast media","volume":"106","author":"Pinnobphun","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.09.011_bib0018","first-page":"84","article-title":"Selective hypersensitivity to cefazolin and contribution of the basophil activation test","volume":"49","author":"Almeida","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.09.011_bib0019","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/iid3.175","article-title":"Utility of basophil activation testing to assess perioperative anaphylactic reactions in real-world practice","volume":"5","author":"Eberlein","year":"2017","journal-title":"Immun Inflamm Dis"},{"issue":"11","key":"10.1016\/j.anai.2022.09.011_bib0020","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1111\/j.1365-2222.2004.02110.x","article-title":"The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams","volume":"34","author":"Torres","year":"2004","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.anai.2022.09.011_bib0021","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/jdv.14890","article-title":"The measurement of drug-induced interferon gamma-releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions","volume":"32","author":"Suthumchai","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.anai.2022.09.011_bib0022","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaip.2018.05.004","article-title":"Analysis of HLA-B allelic variation and IFN-\u03b3 ELISPOT responses in patients with severe cutaneous adverse reactions associated with drugs","volume":"7","author":"Klaewsongkram","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2022.09.011_bib0023","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.jaip.2020.12.052","article-title":"The role of in vivo and ex vivo diagnostic tools in severe delayed immune-mediated adverse antibiotic drug reactions","volume":"9","author":"Copaescu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2022.09.011_bib0024","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2022.09.011_bib0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0300-483X(02)00255-X","article-title":"The danger hypothesis\u2013potential role in idiosyncratic drug reactions","volume":"181-182","author":"Pirmohamed","year":"2002","journal-title":"Toxicology"}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622017197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622017197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:30:52Z","timestamp":1761053452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120622017197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1081120622017197"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2022.09.011","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-lactam hypersensitivity diagnosis in ambulatory and hospitalized settings require different approaches","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2022.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}